(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 4.45% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.33%.
Revvity's revenue in 2025 is $2,798,467,000.On average, 22 Wall Street analysts forecast RVTY's revenue for 2025 to be $337,422,990,060, with the lowest RVTY revenue forecast at $322,797,844,980, and the highest RVTY revenue forecast at $348,798,102,900. On average, 22 Wall Street analysts forecast RVTY's revenue for 2026 to be $349,726,683,540, with the lowest RVTY revenue forecast at $332,199,723,960, and the highest RVTY revenue forecast at $372,128,691,480.
In 2027, RVTY is forecast to generate $372,128,691,480 in revenue, with the lowest revenue forecast at $347,985,594,840 and the highest revenue forecast at $400,102,183,260.